My NCBI | Sign In
RSS Settings
  • Search: Kellogg AP[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.

    Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R.

    Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H453-61. Epub 2008 Dec 5.PMID: 19060127 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy.

    Kellogg AP, Cheng HT, Pop-Busui R.

    Curr Drug Targets. 2008 Jan;9(1):68-76. Review.PMID: 18220714 [PubMed - indexed for MEDLINE]Related articles

    3.

    Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.

    Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R.

    Diabetes. 2007 Dec;56(12):2997-3005. Epub 2007 Aug 24.PMID: 17720896 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.

    Kellogg AP, Pop-Busui R.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1521-9.PMID: 16356116 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity